ABEO Abeona Therapeutics
- 4.5800
- +0.3800+9.05%
Abeona Therapeutics News
ABEONA THERAPEUTICS INC. Q1 Loss Increases, Misses Estimates
Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May Is Expected To Provide Cash Runway Into 2026
Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May
Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate
Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate
Abeona Therapeutics | 10-Q: Quarterly report
Press Release: Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, ex
Abeona Therapeutics 1Q Loss/Shr $1.16 >ABEO
Abeona Therapeutics 1Q Loss/Shr $1.16 >ABEO
Plunge for Elodie Raises $2.5M+ for Life-Saving Rare Disease Research in Just 7 Years
Celebrities, sports teams, schools and supporters across 20+ locations worldwide take polar plunges to raise awareness and funds for rare genetic skin disorder called EBNEW YORK, May 7, 2024 /PRNewsw
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, May 07, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in
Abeona Therapeutics Shares Rise After Underwritten Offering Gets Priced
By Dean Seal Shares of Abeona Therapeutics jumped after the company's underwritten offering was priced to raise $75 million. The stock was up 21% at $4.92 in early trading. Shares are about 2% below
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
CLEVELAND, May 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) ("Abeona" or the "Company") today announced the pricing of an underwritten offering of 12,285,056 shares of its common stock and, in
Abeona Therapeutics(ABEO.US) Officer Buys US$32,000 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Officer Seshadri Vishwas purchased 10,000 shares of common stock on Apr 25, 2024 at an average price of $3.2 for a total value of $32,000.Source: Announcement What is st
Abeona Therapeutics(ABEO.US) Director Buys US$24,764 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Director Charles Faith L. purchased 7,550 shares of common stock on Apr 26, 2024 at an average price of $3.28 for a total value of $24,764.Source: Announcement What is s
Abeona Therapeutics(ABEO.US) Officer Buys US$27,864 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Officer O'Malley Brendan M. purchased 8,600 shares of common stock on Apr 25, 2024 at an average price of $3.24 for a total value of $27,864.Source: Announcement What is
Abeona Therapeutics(ABEO.US) Officer Buys US$17,609.12 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Officer Vazzano Joseph Walter purchased 5,608 shares of common stock on Apr 25, 2024 at an average price of $3.14 for a total value of $17,609.12.Source: Announcement Wh
Abeona Therapeutics: Key Director Elections and Share Resolutions Passed
Insider Buyers Lose Additional US$35k As Abeona Therapeutics Dips To US$93m
The recent 57% drop in Abeona Therapeutics Inc.'s (NASDAQ:ABEO) stock could come as a blow to insiders who purchased US$192.1k worth of stock at an average buy price of US$4.18 over the past 12 months
Sector Update: Health Care Stocks Rise Late Afternoon
Health care stocks gained late Tuesday afternoon, with the NYSE Health Care Index climbing 1.3% and the Health Care Select Sector SPDR Fund (XLV) adding 1.2%. The iShares Biotechnology ETF (IBB) climb
Top Midday Decliners
Abeona Therapeutics (ABEO) shares sank nearly 54% amid heavy trading after the company said late Monday that it plans to resubmit its biologic license application for pz-cel after the US Food and Drug
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
KOPN, BTCM and CETX Among Mid-day Movers
Analysis
Price Target
No Data
